Search by Drug Name or NDC
NDC 63304-0926-05 Guanfacine 3 mg/1 Details
Guanfacine 3 mg/1
Guanfacine is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc. The primary component is GUANFACINE HYDROCHLORIDE.
Product Information
| NDC | 63304-0926 |
|---|---|
| Product ID | 63304-926_ccff8408-b71e-434b-96ce-42827aa6c362 |
| Associated GPIs | 61353030107540 |
| GCN Sequence Number | 065573 |
| GCN Sequence Number Description | guanfacine HCl TAB ER 24H 3 MG ORAL |
| HIC3 | H8M |
| HIC3 Description | TX FOR ADHD - SELECTIVE ALPHA-2 RECEPTOR AGONIST |
| GCN | 27579 |
| HICL Sequence Number | 000120 |
| HICL Sequence Number Description | GUANFACINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Guanfacine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Guanfacine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 3 |
| Active Ingredient Units | mg/1 |
| Substance Name | GUANFACINE HYDROCHLORIDE |
| Labeler Name | Sun Pharmaceutical Industries, Inc |
| Pharmaceutical Class | Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA205689 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63304-0926-05 (63304092605)
| NDC Package Code | 63304-926-05 |
|---|---|
| Billing NDC | 63304092605 |
| Package | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-926-05) |
| Marketing Start Date | 2018-08-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |